Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fleur M Ferguson

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Current Research in Chemical Biology|August 21, 2025
Synthesis and structure-activity relationships of targeted protein degraders for the understudied kinase NEK9SeongShick Ryu, Gillian E Gadbois, Andrew J Tao, et al.
Cell Chemical Biology|April 2, 2019
Discovery of Covalent CDK14 Inhibitors with Pan-TAIRE Family SpecificityFleur M Ferguson, Zainab M Doctor, Scott B Ficarro, et al.
European Journal of Medicinal Chemistry|May 4, 2021
Structure-activity relationship study of THZ531 derivatives enables the discovery of BSJ-01-175 as a dual CDK12/13 covalent inhibitor with efficacy in Ewing sarcomaBaishan Jiang, Jie Jiang, Ines H Kaltheuner, et al.
Nature Genetics|June 3, 2020
Selective Mediator dependence of cell-type-specifying transcriptionMartin G Jaeger, Björn Schwalb, Sebastian D Mackowiak, et al.
Angewandte Chemie (International Ed. in English)|November 27, 2024
A Kinetic Scout Approach Accelerates Targeted Protein Degrader DevelopmentAngela T Fan, Gillian E Gadbois, Hai-Tsang Huang, et al.
Journal of Medicinal Chemistry|April 17, 2020
Discovery and Structure-Activity Relationship Study of (<i>Z</i>)-5-Methylenethiazolidin-4-one Derivatives as Potent and Selective Pan-phosphatidylinositol 5-Phosphate 4-Kinase InhibitorsTheresa D Manz, Sindhu Carmen Sivakumaren, Fleur M Ferguson, et al.
Science Signaling|September 17, 2024
DCLK1 induces a pro-tumorigenic phenotype to drive gastric cancer progressionShoukat Afshar-Sterle, Annalisa L E Carli, Ryan O'Keefe, et al.
Nature Chemical Biology|August 11, 2025
ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDACNathan L Tran, Jiewei Jiang, Min Ma, et al.
Cancer Cell|July 30, 2021
TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcomaBo Kyung A Seong, Neekesh V Dharia, Shan Lin, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Structure-Activity Relationship Study of Covalent Pan-phosphatidylinositol 5-Phosphate 4-Kinase InhibitorsTheresa D Manz, Sindhu C Sivakumaren, Adam Yasgar, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Current Research in Chemical Biology|August 21, 2025
Synthesis and structure-activity relationships of targeted protein degraders for the understudied kinase NEK9SeongShick Ryu, Gillian E Gadbois, Andrew J Tao, et al.
Cell Chemical Biology|April 2, 2019
Discovery of Covalent CDK14 Inhibitors with Pan-TAIRE Family SpecificityFleur M Ferguson, Zainab M Doctor, Scott B Ficarro, et al.
European Journal of Medicinal Chemistry|May 4, 2021
Structure-activity relationship study of THZ531 derivatives enables the discovery of BSJ-01-175 as a dual CDK12/13 covalent inhibitor with efficacy in Ewing sarcomaBaishan Jiang, Jie Jiang, Ines H Kaltheuner, et al.
Nature Genetics|June 3, 2020
Selective Mediator dependence of cell-type-specifying transcriptionMartin G Jaeger, Björn Schwalb, Sebastian D Mackowiak, et al.
Angewandte Chemie (International Ed. in English)|November 27, 2024
A Kinetic Scout Approach Accelerates Targeted Protein Degrader DevelopmentAngela T Fan, Gillian E Gadbois, Hai-Tsang Huang, et al.
Journal of Medicinal Chemistry|April 17, 2020
Discovery and Structure-Activity Relationship Study of (<i>Z</i>)-5-Methylenethiazolidin-4-one Derivatives as Potent and Selective Pan-phosphatidylinositol 5-Phosphate 4-Kinase InhibitorsTheresa D Manz, Sindhu Carmen Sivakumaren, Fleur M Ferguson, et al.
Science Signaling|September 17, 2024
DCLK1 induces a pro-tumorigenic phenotype to drive gastric cancer progressionShoukat Afshar-Sterle, Annalisa L E Carli, Ryan O'Keefe, et al.
Nature Chemical Biology|August 11, 2025
ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDACNathan L Tran, Jiewei Jiang, Min Ma, et al.
Cancer Cell|July 30, 2021
TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcomaBo Kyung A Seong, Neekesh V Dharia, Shan Lin, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Structure-Activity Relationship Study of Covalent Pan-phosphatidylinositol 5-Phosphate 4-Kinase InhibitorsTheresa D Manz, Sindhu C Sivakumaren, Adam Yasgar, et al.
Pageof 6